SEC Form 4 · accession 0001209191-15-001372
Tobira Therapeutics, Inc. · TBRA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Pierre Legault
Director
Period of report
Jan 1, 2015
Accepted (ET)
Jan 5, 2015 · 6:16 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001311596
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock (right to buy)F1 | $0.91 | Jan 1, 2015 | A | 159,261 | A | — | Jan 1, 2025 | Common Stock | 159,261 | 159,261 | D |
Explanation of responses
- F1159,261 shares subject to the stock option shall vest on the first anniversary of the date of grant.